Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alto Ingredients, Inc.

1.02
+0.07898.38%
Post-market: 1.020.00000.00%19:33 EDT
Volume:296.31K
Turnover:298.54K
Market Cap:78.76M
PE:-1.25
High:1.04
Open:0.9799
Low:0.9503
Close:0.9411
Loading ...

Alto Neuroscience Presents Data at the 2025 American Society of Clinical Psychopharmacology Annual Meeting Reinforcing Safety and Tolerability Profile for ALTO-300 in Major Depressive Disorder

Business Wire
·
29 May

Alto Ingredients Inc. Faces Nasdaq Delisting Risk Due to Stock Price Falling Below $1 Threshold

Reuters
·
24 May

Alto Ingredients Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
08 May

Alto Ingredients Q1 EPS $(0.16) Beats $(0.20) Estimate, Sales $226.54M Beat $222.19M Estimate

Benzinga
·
08 May

BRIEF-Alto Ingredients Q1 EPS USD -0.16

Reuters
·
08 May

Alto Ingredients Q1 Sales USD 226.5 Million

THOMSON REUTERS
·
08 May

Alto Ingredients Inc expected to post a loss of 20 cents a share - Earnings Preview

Reuters
·
06 May

Alto Ingredients Inc expected to post a loss of 20 cents a share - Earnings Preview

Reuters
·
02 May

Reversal Of Fortune For Alto Ingredients Insiders Who Made A US$6.45m Purchase

Simply Wall St.
·
26 Apr

Alto Ingredients directors Kieta, Kandris to not stand for reelection

TIPRANKS
·
18 Mar

Alto Ingredients enters intoletter agreement with Bradley Radoff, Michael Torok

TIPRANKS
·
18 Mar

Alto Ingredients, Inc. Directors to Not Stand for Reelection

GlobeNewswire
·
18 Mar

Alto Ingredients, Inc. Enters Into Letter Agreement With Bradley L. Radoff and Michael Torok

THOMSON REUTERS
·
18 Mar

Alto Ingredients, Inc. Enters into Letter Agreement with Bradley L. Radoff and Michael Torok

GlobeNewswire
·
18 Mar

Alto Ingredients, Inc.'s (NASDAQ:ALTO) largest shareholders are individual investors with 53% ownership, institutions own 37%

Simply Wall St.
·
10 Mar

Alto Ingredients Price Target Maintained With a $5.50/Share by HC Wainwright & Co.

Dow Jones
·
06 Mar

Alto Ingredients Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
06 Mar

Alto Ingredients Q4 GAAP EPS (0.57) Down from (0.26) YoY, Sales $236.35M Down from $273.625M YoY.

Benzinga
·
06 Mar

BRIEF-Alto Ingredients Q4 EPS USD -0.57

Reuters
·
06 Mar

Alto Ingredients Inc - Lowers Company Headcount by 16%

THOMSON REUTERS
·
06 Mar